Skip to content Skip to footer

Author page: admin

HomeAuthor page: admin
September 24, 2021

Sepsivac

Biocon’s Itolizumab Has Received The Drugs Controller General Of India’s (DCGI) Approval For Emergency Use In The Treatment Of Cytokine Release Syndrome (CRS) In Moderate To Severe ARDS (Acute Respiratory Distress Syndrome) Patients Due To COVID-19 How does it Work? Itolizumab Mechanism Of Action Itolizumab’s unique mechanism of action…
News0Comments24Views
September 24, 2021

Itolizumab

Biocon’s Itolizumab Has Received The Drugs Controller General Of India’s (DCGI) Approval For Emergency Use In The Treatment Of Cytokine Release Syndrome (CRS) In Moderate To Severe ARDS (Acute Respiratory Distress Syndrome) Patients Due To COVID-19 How does it Work? Itolizumab Mechanism Of Action Itolizumab’s unique mechanism of action…
News, Uncategorized0Comments20Views
September 24, 2021

Temziva

Temziva™ contains the active substance tocilizumab, which is a protein made from soecific immune cells (monoclonal antibody), that blocks the action of a specific protein (cytokine) called interleukin-6. IL-6 activity in body causes many symptoms of autoimmune disease such as Rheumatoid Arthtitis (RA). Blocking IL-6 receptors can reduce…
All Products, Antibacterial0Comments18Views